A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients

Journal of Critical Care

Volumn 24, Issue 4, 2009, Pages 568-574

  Gerlach, Anthony T ^a   Dasta, Joseph F ^b,c   Steinberg, Steven ^a   Martin, Larry C ^d   Cook, Charles H ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Dexmedetomidine; Hypotension; Intensive care unit

Indexed keywords

DEXMEDETOMIDINE;

ADULT; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; FEMALE; HUMAN; HYPOTENSION; INTENSIVE CARE; MALE; OUTCOME ASSESSMENT; SEDATION; SURGICAL PATIENT;

ADULT; AGED; BRADYCARDIA; CLINICAL PROTOCOLS; CRITICAL ILLNESS; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 70449526302     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.05.015     Document Type: Article

References (28)

1. In: Kohn L.T., Corrigan J.M., and Donaldson M.S. (Eds). To err is human: Building a safer health system (1999), National Academy Press, Washington. DC
2. Hussain E., and Kao E. Medication safety and transfusion errors in the ICU and beyond. Crit Care Clin 21 (2005) 91-110
3. Pronovost P., Wu A.W., Dorman T., and Morlock L. Building safety into ICU care. J Crit Care 17 (2002) 78-85
4. Calabrese A.D., Erstad B.L., Brandl K., Barletta J., Kane S.L., and Sherman D. Medication administration errors in adult patient in the intensive care unit. Intensive Care Med 27 15 (2001) 92-1598
5. Cullen D.J., Sweitzer B.J., Bates D.W., Burdick E., Edmondson A., and Leape L.L. Preventable adverse drug events in hospitalized patients: a comparison of intensive care and general care units. Crit Care Med 25 (1997) 1289-1297
6. Kane-Gill S.L., and Weber R.J. Principles and practices of medication errors in the ICU. Crit Care Clin 22 (2006) 273-290
7. Jacobi J., Fraser G.L., Coursin D.B., Riker R.R., Fontaine D., Wittbrodt E.T., et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30 (2002) 119-141
8. Kollef M.H., Levy NT Ahrens T.S., Schaiff R., Prentice D., and Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 114 (1998) 541-548
9. Gerlach A.T., and Dasta J.F. Dexmedetomidine: an updated review. Ann Pharmacother 41 (2007) 245-254
10. Product Information Precedex (dexmedetomidine) Lake Forrest, IL; Hospira, 2008.
11. Bhana N., Goa K.L., and McClellan K. Dexmedetomidine. Drugs 59 (2000) 263-268
12. Pandharipande P.P., Ely E.W., and Maze M. Dexmedetomidine for sedation and perioperative management of critically ill patients. Semin Anesth Periop Med Pain 25 (2006) 43-50
13. Gerlach A.T., Dasta J.F., Martin L.M., and Cook C.H. Effect of titration methods on adverse reactions to dexmedetomidine. (abstr). Crit Care Med 33 (2005) A112
14. Sessler C.N., Gosnell M.S., Grap M.J., Brophy G.M., O'Neal P.V., Keane K.A., et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166 (2002) 1338-1344
15. Elbaradie S., El Mahalawy F.H., and Solyman A.H. Dexmedetomidine versus propofol for short-term sedation of postoperative mechanically ventilated patients. J Egyptian Nat Cancer Inst 16 (2004) 153-158
16. Venn R.M., Bradshaw C.J., Spencer R., Brealey D., Caudwell E., Naughton C., et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesth 54 (1999) 1136-1142
17. Pandharipande P.P., Pun B.T., Herr D.L., Maze M., Girard T.G., Miller R., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients. JAMA 298 (2007) 2644-2653
18. Herr D.L., Sum-Ping S.T., and England M. ICU sedation after coronary artery bypass surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothor Vasc Anesth 17 (2003) 576-584
19. Venn R.M., and Grounds R.M. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 87 (2001) 884-890
20. Corbett S.M., Rebuck J.A., Greene C.M., Callas P.W., Neale B.W., Healey M.A., et al. Dexmedetomidine does not improve patients satisfaction when compared to propofol during mechanical ventilation. Crit Care Med 33 (2005) 940-945
21. Ickeringill M., Shehabi Y., Adamson H., and Reuttimann U. Dexmedetomidine infusion without loading infusion in surgical patients requiring mechanical ventilation; hemodynamic effects and efficacy. Anaesth Intensive Care 32 (2004) 741-745
22. Riker R.R., Shehabi Y., Bokesch P.M., Ceraso D., Wisemandle W., Koura F., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301 (2009) 489-499
23. Dasta J.F., Kane-Gill S.L., and Durtschi A.J. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother 38 (2004) 1130-1135
24. Ebert T.J., Hall J.E., Barney J.A., Uhrich T.D., and Colinco M.D. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93 (2000) 382-394
25. Venn R.M., Karol M.D., and Grounds R.M. Pharmacokinetics of dexmedetomidine infusion for sedation of postoperative patients requiring intensive care. Br J Anesth 88 (2002) 669-675
26. Shehabi Y., Ruettimann U., Adamson H., Innes R., and Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 30 (2004) 2188-2196
27. Buck M.L., and Willson D.F. Use of dexmedetomidine in the pediatric intensive care unit. Pharmacotherapy 28 (2008) 51-57
28. Venn R.M., Newmann P.J., and Grounds R.M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care units. Intensive Care Med 29 (2003) 201-207